| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |